13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
42 檔
13.9%
According to the latest 13F quarterly dataset, Sabby Management, LLC managed an equity portfolio of $110.5M at the end of Q3 2024, spanning 42 distinct U.S. exchange-listed positions.
Sabby Management, LLC executed strategic sector rebalancing during Q3 2024, establishing 23 new positions while fully exiting 20 holdings and trimming 8 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Core Scientific Inc New | Stock-Other | 40.50% | — | +27.17% | |
| 2 | VANI | Vivani Medical Inc | Stock-Other | 11.32% | — | +0.09% | |
| 3 | ✓ | Bit Digital Inc | Stock-Other | 9.96% | — | +44.94% | |
| 4 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 4.36% | — | +531.51% | |
| 5 | ✓ | Volcon Inc | Stock-Other | 3.66% | — | — | |
| 6 | HCWC | Healthy Choice Wellness CORP | Stock-Other | 3.43% | — | — | |
| 7 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 3.25% | +45.73% | +13.99% | |
| 8 | CLSNEUR | Imunon Inc | Stock-Other | 2.93% | — | — | |
| 9 | CORZ | Core Scientific, Inc. | Stock-Tech | 2.26% | — | -15.18% | |
| 10 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 1.95% | +13.85% | NEW | |
| 11 | ✓ | Ishares Tr | Stock-Other | 1.88% | +11.16% | -25.29% | |
| 12 | CORZ | Core Scientific Inc | Stock-Tech | 1.83% | — | — | |
| 13 | ✓ | Checkpoint Therapeutics Inc | Stock-Other | 1.79% | — | -34.97% | |
| 14 | ✓ | Stock-Other | 1.69% | — | — | ||
| 15 | ✓ | Ensysce Biosciences Inc | Stock-Other | 1.27% | — | +269.84% | |
| 16 | SCPX | Scorpius Holdings Inc | Stock-Other | 1.13% | — | — | |
| 17 | ✓ | Stock-Other | 0.96% | — | — | ||
| 18 | ATXI | Avenue Therapeutics Inc | Stock-Other | 0.71% | — | +68.64% | |
| 19 | SNES | Senestech Inc | Stock-Other | 0.65% | -3.82% | — | |
| 20 | ✓ | Stock-Other | 0.60% | — | — | ||
| 21 | ✓ | Nrx Pharmaceuticals Inc | Stock-Other | 0.59% | — | +44.91% | |
| 22 | ✓ | Stock-Other | 0.57% | — | — | ||
| 23 | ✓ | Ishares Tr | Stock-Other | 0.46% | +12.02% | NEW | |
| 24 | PHIO | Phio Pharmaceuticals CORP | Stock-Other | 0.39% | — | — | |
| 25 | SIDU | Sidus Space Inc-cl A | Stock-Other | 0.38% | +0.11% | NEW | |
| 26 | NRXP | Nrx Pharmaceuticals Inc | Stock-Other | 0.27% | — | — | |
| 27 | VVOS | Vivos Therapeutics Inc | Stock-Other | 0.24% | — | — | |
| 28 | ✓ | Bluejay Diagnostics Inc | Stock-Other | 0.18% | — | — | |
| 29 | ✓ | Revelation Biosciences Inc | Stock-Other | 0.16% | — | — | |
| 30 | ✓ | Stock-Other | 0.16% | — | — | ||
| 31 | KPRX | Kiora Pharmaceuticals Inc | Stock-Other | 0.08% | — | — | |
| 32 | ✓ | Globus Maritime Limited New | Stock-Other | 0.08% | — | — | |
| 33 | SXTPW | 60 Degrees Pharma Inc-28 | Stock-Other | 0.07% | — | -8.28% | |
| 34 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 0.06% | — | — | |
| 35 | AMPGW | Amplitech Group Inc-cw26 | Stock-Other | 0.04% | — | -40.68% | |
| 36 | ✓ | Stock-Other | 0.03% | — | — | ||
| 37 | ✓ | Scilex Holding Co | Stock-Other | 0.02% | — | — | |
| 38 | SCLXUSD | Scilex Holding Co | Stock-Other | 0.02% | — | — | |
| 39 | ✓ | Stock-Other | 0.01% | — | — | ||
| 40 | ✓ | Wearable Devices LTD | Stock-Other | 0.01% | — | -33.34% | |
| 41 | EFTR | Effector Therapeutics Inc | Stock-Other | 0.01% | — | -82.46% | |
| 42 | ✓ | Atossa Therapeutics Inc | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Core Scientific Inc New | +33% | +27.17% | Add |
| 2 | ✓ | Bit Digital Inc | +8.1% | +44.94% | Add |
| 3 | VANI | Vivani Medical Inc | +7.7% | +0.09% | Add |
| 4 | ✓ | Eos Energy Enterprises Inc | +4.3% | +531.51% | Add |
| 5 | ✓ | Volcon Inc | +3.7% | NEW | New buy |
| 6 | HCWC | Healthy Choice Wellness CORP | +3.4% | NEW | New buy |
| 7 | CLSNEUR | Imunon Inc | +2.9% | NEW | New buy |
| 8 | ✓ | Spdr S&P 500 Etf Tr Put Option | +2.4% | +13.99% | Add |
| 9 | CORZ | Core Scientific Inc | +1.8% | NEW | New buy |
| 10 | SPY | State Street SPDR S&P 500 ETF Trust | +1.7% | +146.38% | Add |
| 11 | ✓ | +1.7% | NEW | New buy | |
| 12 | CORZ | Core Scientific, Inc. | +1.6% | -15.18% | Trim |
| 13 | SCPX | Scorpius Holdings Inc | +1.1% | NEW | New buy |
| 14 | ✓ | Ensysce Biosciences Inc | +1.1% | +269.84% | Add |
| 15 | ✓ | Checkpoint Therapeutics Inc | +1% | -34.97% | Trim |
| 16 | ✓ | +1% | NEW | New buy | |
| 17 | SNES | Senestech Inc | +0.7% | NEW | New buy |
| 18 | ✓ | +0.6% | NEW | New buy | |
| 19 | ✓ | +0.6% | NEW | New buy | |
| 20 | ATXI | Avenue Therapeutics Inc | +0.5% | +68.64% | Add |
| 21 | ✓ | Nrx Pharmaceuticals Inc | +0.4% | +44.91% | Add |
| 22 | PHIO | Phio Pharmaceuticals CORP | +0.4% | NEW | New buy |
| 23 | NRXP | Nrx Pharmaceuticals Inc | +0.3% | NEW | New buy |
| 24 | VVOS | Vivos Therapeutics Inc | +0.2% | NEW | New buy |
| 25 | ✓ | Bluejay Diagnostics Inc | +0.2% | NEW | New buy |
| 26 | ✓ | Revelation Biosciences Inc | +0.2% | NEW | New buy |
| 27 | ✓ | +0.2% | NEW | New buy | |
| 28 | SIDU | Sidus Space Inc-cl A | +0.1% | -63.78% | Trim |
| 29 | KPRX | Kiora Pharmaceuticals Inc | +0.1% | NEW | New buy |
| 30 | ✓ | Reviva Pharmaceutcls Hldgs Inc | +0.1% | NEW | New buy |
| 31 | ✓ | Globus Maritime Limited New | +0.1% | — | Unchanged |
| 32 | SXTPW | 60 Degrees Pharma Inc-28 | 0% | -8.28% | Trim |
| 33 | ✓ | 0% | NEW | New buy | |
| 34 | AMPGW | Amplitech Group Inc-cw26 | 0% | -40.68% | Trim |
| 35 | ✓ | Scilex Holding Co | 0% | NEW | New buy |
| 36 | SCLXUSD | Scilex Holding Co | 0% | NEW | New buy |
| 37 | ✓ | 0% | NEW | New buy | |
| 38 | ✓ | Atossa Therapeutics Inc | 0% | NEW | New buy |
| 39 | ✓ | Wearable Devices LTD | 0% | -33.34% | Trim |
| 40 | ✓ | 0% | EXIT | Sold out | |
| 41 | CINGW | Cingulate -cw23 | 0% | EXIT | Sold out |
| 42 | ✓ | Applied Dna Sciences Inc | 0% | EXIT | Sold out |
| 43 | SCNI | Scinai Immunotherapeutics Lt | -0.1% | EXIT | Sold out |
| 44 | ✓ | Gevo Inc | -0.1% | EXIT | Sold out |
| 45 | ✓ | China Natural Resources Inc | -0.1% | EXIT | Sold out |
| 46 | ✓ | Inmed Pharmaceuticals Inc | -0.1% | EXIT | Sold out |
| 47 | EFTR | Effector Therapeutics Inc | -0.1% | -82.46% | Trim |
| 48 | SMFL | Smart For Life Inc | -0.1% | EXIT | Sold out |
| 49 | GEVO | Gevo Inc | -0.2% | EXIT | Sold out |
| 50 | NEXI | Neximmune Inc | -0.2% | EXIT | Sold out |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 42 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including CORE SCIENTIFIC INC NEW, VANI, BIT DIGITAL INC) accounted for 13.9% of total reported equity market value during Q3 2024.
Top New Position Initiated
VOLCON INC
市值: $805.6K
Top Position Liquidated / Trimmed
CORZW
前期市值: $762.1K
During Q3 2024, Sabby Management, LLC's top holdings by market value included CORE SCIENTIFIC INC NEW (40.5%)、VANI (11.3%)、BIT DIGITAL INC (10.0%). The largest single position, CORE SCIENTIFIC INC NEW, represented 40.5% of total portfolio value.
In Q3 2024, Sabby Management, LLC made 61 total portfolio adjustments, initiating 23 new buys, adding to 10 positions, trimming 8 holdings, and fully liquidating 20 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.